S

Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185

Watchlist Manager
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
Watchlist
Price: 4.13 HKD -0.48%
Market Cap: HK$1B

Multiples-Based Value

2185 price has not been updated for more than 11 months. This may indicate that the stock has been delisted.

The Multiples-Based Value of one Shanghai Bio-heart Biological Technology Co Ltd stock under the Base Case scenario is 0.4 HKD. Compared to the current market price of 4.13 HKD, Shanghai Bio-heart Biological Technology Co Ltd is Overvalued by 90%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Multiples-Based Value
Base Case
0.4 HKD
Overvaluation 90%
Multiples-Based Value
Price HK$4.13
S
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Shanghai Bio-heart Biological Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
1B HKD 42.5 -9.9 -9 -8.1
US
Abbott Laboratories
NYSE:ABT
178.6B USD 4 27.4 15.7 21.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
160.5B USD 15.9 56.2 42.5 52.3
US
Stryker Corp
NYSE:SYK
126.8B USD 5 39.1 20 24.2
IE
Medtronic PLC
NYSE:MDT
111.2B USD 3.1 24.1 13.3 19.4
US
Boston Scientific Corp
NYSE:BSX
93.2B USD 4.6 32.1 19.1 25.6
US
Edwards Lifesciences Corp
NYSE:EW
47.1B USD 7.8 43.9 24.1 26.4
DE
Siemens Healthineers AG
XETRA:SHL
40.6B EUR 1.7 19.2 10.8 15.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.4B USD 10.6 42.9 30.4 33.6
US
Becton Dickinson and Co
NYSE:BDX
44B USD 2 25 9.9 16.8
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
32.1B USD 1.6 15.4 11.1 13.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett